Brought to you by 
Angiotech nets $17mm in an IPO of 2.4mm common shares
05 Aug 1999
Executive Summary
Angiotech Pharmaceuticals, a company with a focus on treatments for inflammatory and angiogenesis-dependent diseases, has netted $17.1mm (Cdn$23.7mm) (including greenshoe) in an IPO of 2.4mm common shares at $7 (Cdn$10) each.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Angiotech nets $17mm in an IPO of 2.4mm common shares
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice